# HeartR™ PDA Occluder Post-Market Follow-Up Study

> **NCT07646704** · — · RECRUITING · sponsor: **Lifetech Scientific (Shenzhen) Co., Ltd.** · enrollment: 140 (estimated)

## Conditions studied

- Patent Ductus Arteriosus

## Interventions

- **DEVICE:** HeartR™ PDA Occluder

## Key facts

- **NCT ID:** NCT07646704
- **Lead sponsor:** Lifetech Scientific (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-30
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07646704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07646704, "HeartR™ PDA Occluder Post-Market Follow-Up Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07646704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*